Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ArriVent Appoints Brent Rice as Chief Commercial Officer

Summary by Citybiz
NEWTOWN SQUARE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc. (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Brent S. Rice as Chief Commercial Officer (CCO). Mr. Rice joins ArriVent with over 25 years of U.S. and global commercial experience in the biotechnology and pharmaceutical industry. “Brent brings a…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

citybizcitybiz

ArriVent Appoints Brent Rice as Chief Commercial Officer

NEWTOWN SQUARE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc. (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Brent S. Rice as Chief Commercial Officer (CCO). Mr. Rice joins ArriVent with over 25 years of U.S. and global commercial experience in the biotechnology and pharmaceutical industry. “Brent brings a…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

citybiz broke the news in on Monday, September 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Newtown Square icon

Newtown Square

News
For You
SearchBlindspotLocal